Page 21 - Numinus Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Non-Traditional Therapies Could Fill Vital Mental Health Needs - FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, March 2, 2021 /PRNewswire/ -- Non-traditional therapies are coming a long way from their stigmatized roots. Rising rates of serious mental health issues and unreliability of traditional mental health treatments have spurred research into treatment forms utilizing once stigmatized and criminalized drugs. The results have been promising enough that the pharmaceutical industry around therapeutic MDMA, ketamine, psilocybin, and other psychoactive substances is tak...

As “Shrooms” Fix the World’s Largest Healthcare Crisis, This Tiny Stock Will Soar InvestorPlace 3/1/2021 1 in 11 Canadians will have PTSD in their lifetime. 1 in 5 Canadians will suffer from addiction. 450,000 people worldwide died from drug use in 2015. 971 million people worldwide suffer from a mental or substance use disorder. These statistics clearly illustrate two things: Mental health and substance abuse is a global epidemic. Current medications are failing to address this epidemic. To that end, a breakthrough, novel therapy is needed to fix what may be the world’s biggest hea...

relieve anxiety and depression levels in people with life-threatening cancer diagnoses four-times better than traditional antidepressants on the market. That finding corroborates a previous NYU study, which found that psilocybin causes a “ rapid and sustained” reduction in anxiety and depression levels in cancer patients. Meanwhile, a recent UC Davis study found that psychedelic micro-dosing can produce beneficial behavioral effects in patients with mental health disorders. The list of academic studies goes on and on. This groundbreaking research has coupled with shifting public percep...

Mental Health Demand For Development Of Psychedelic Drug Therapies Is Increasing PALM BEACH, Fla., Jan. 12, 2021 /PRNewswire/ -- After being relegated to the margins of sincere scientific examination for about five decades, growing researchers and scientists are exploring the therapeutic value of psychedelic drugs and compounds that could be a new treatment option for people with depression. According to Data Bridge Market Research North America psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the mar...

North America Psychedelic Drugs Market Could Exceed $6.8 Billion By 2027 - Financialnewsmedia.com News Commentary PALM BEACH, Fla., Jan. 6, 2021 /PRNewswire/ -- In the few places where cannabis is legal, it can be incredibly lucrative. In 2019, the nascent worldwide cannabis sector pumped out approximately $15 billion in sales. By 2024, that number is expected to triple. Not bad for an industry that, less than a decade ago, was entirely illegal almost everywhere on Earth and is still outlawed in most countries. Now, startups and investors are positioning to profit from psilocybin, LSD and oth...